ZNF827 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.294390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.828400E-01
Normal-vs-Stage2
7.966300E-02
Normal-vs-Stage3
2.272600E-01
Normal-vs-Stage4
9.261000E-01
Stage1-vs-Stage2
3.265600E-01
Stage1-vs-Stage3
2.625900E-02
Stage1-vs-Stage4
5.184200E-01
Stage2-vs-Stage3
9.443800E-02
Stage2-vs-Stage4
7.594100E-02
Stage3-vs-Stage4
7.632200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.116200E-01
Normal-vs-AfricanAmerican
4.784800E-01
Normal-vs-Asian
2.818400E-01
Caucasian-vs-AfricanAmerican
4.560600E-01
Caucasian-vs-Asian
9.341800E-01
AfricanAmerican-vs-Asian
5.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.555610E-01
Normal-vs-Female
1.248970E-01
Male-vs-Female
6.976200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.297800E-01
Normal-vs-Age(41-60Yrs)
3.419600E-01
Normal-vs-Age(61-80Yrs)
8.996100E-02
Normal-vs-Age(81-100Yrs)
6.124100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.828200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.862400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.431200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.610400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.952200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.057800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.257900E-02
Normal-vs-Daily Drinker
3.965900E-02
Normal-vs-Weekly Drinker
1.131030E-01
Normal-vs-Occasional Drinker
6.267400E-01
Normal-vs-Social Drinker
3.026400E-01
Non Drinker-vs-Daily Drinker
4.754400E-01
Non Drinker-vs-Weekly Drinker
9.180000E-01
Non Drinker-vs-Occasional Drinker
3.228300E-02
Non Drinker-vs-Social Drinker
2.065200E-01
Daily Drinker-vs-Weekly Drinker
6.077600E-01
Daily Drinker-vs-Occasional Drinker
9.019100E-03
Daily Drinker-vs-Social Drinker
5.781900E-02
Weekly Drinker-vs-Occasional Drinker
6.589900E-02
Weekly Drinker-vs-Social Drinker
2.264000E-01
Occasional Drinker-vs-Social Drinker
4.102800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.867620E-01
Normal-vs-Grade 2
3.031800E-02
Normal-vs-Grade 3
3.254100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.203000E-01
Grade 1-vs-Grade 3
5.072400E-01
Grade 1-vs-Grade 4
1.867620E-01
Grade 2-vs-Grade 3
1.074370E-01
Grade 2-vs-Grade 4
3.031800E-02
Grade 3-vs-Grade 4
3.254100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.780000E-02
Normal-vs-NonDiabetic
1.297600E-01
Diabetic-vs-NonDiabetic
5.178800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.551000E-01
Normal-vs-NoPancreatitis
1.258410E-01
Pancreatitis-vs-NoPancreatitis
7.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.203200E-01
Normal-vs-N1
6.990500E-02
N0-vs-N1
4.601400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.173800E-01
Normal-vs-TP53-NonMutant
3.568200E-01
TP53-Mutant-vs-TP53-NonMutant
5.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
